Welltower Inc. (NYSE:WELL) Shares Sold by Cidel Asset Management Inc.

Cidel Asset Management Inc. trimmed its stake in shares of Welltower Inc. (NYSE:WELLFree Report) by 5.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,653 shares of the real estate investment trust’s stock after selling 98 shares during the period. Cidel Asset Management Inc.’s holdings in Welltower were worth $208,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Laurel Wealth Advisors LLC purchased a new position in Welltower during the 4th quarter valued at about $25,000. Fortitude Family Office LLC grew its position in shares of Welltower by 37.0% in the third quarter. Fortitude Family Office LLC now owns 289 shares of the real estate investment trust’s stock valued at $37,000 after purchasing an additional 78 shares during the last quarter. Versant Capital Management Inc increased its stake in shares of Welltower by 165.5% during the 4th quarter. Versant Capital Management Inc now owns 300 shares of the real estate investment trust’s stock worth $38,000 after purchasing an additional 187 shares in the last quarter. Ashton Thomas Securities LLC purchased a new stake in Welltower in the 3rd quarter valued at approximately $50,000. Finally, FSA Wealth Management LLC acquired a new stake in Welltower during the 3rd quarter valued at $59,000. Hedge funds and other institutional investors own 94.80% of the company’s stock.

Welltower Stock Up 0.2 %

Shares of NYSE WELL opened at $142.66 on Monday. The stock has a market capitalization of $88.83 billion, a PE ratio of 93.86, a P/E/G ratio of 2.83 and a beta of 1.23. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The firm has a fifty day moving average of $130.34 and a 200-day moving average of $127.67. Welltower Inc. has a 52-week low of $85.40 and a 52-week high of $143.39.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on WELL shares. Jefferies Financial Group raised Welltower from a “hold” rating to a “buy” rating and boosted their price target for the stock from $132.00 to $147.00 in a report on Thursday, January 2nd. Mizuho boosted their target price on shares of Welltower from $136.00 to $141.00 and gave the company an “outperform” rating in a research note on Thursday, December 5th. Bank of America raised their price target on shares of Welltower from $190.00 to $221.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Scotiabank boosted their price objective on shares of Welltower from $142.00 to $144.00 and gave the company a “sector outperform” rating in a research report on Monday, January 27th. Finally, Raymond James raised their target price on shares of Welltower from $145.00 to $155.00 and gave the stock a “strong-buy” rating in a research report on Monday, December 16th. Five investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $134.96.

Read Our Latest Stock Report on WELL

About Welltower

(Free Report)

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.

Read More

Institutional Ownership by Quarter for Welltower (NYSE:WELL)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.